Please login to the form below

Not currently logged in

Synergy Pharma

This page shows the latest Synergy Pharma news and features for those working in and with pharma, biotech and healthcare.

FDA approves Synergy's constipation drug Trulance

FDA approves Synergy's constipation drug Trulance

Synergy Pharma is celebrating after the FDA approved Trulance, its drug for the treatment of chronic idiopathic constipation (CIC) in adults. ... Synergy estimates that 33 million Americans have CIC, which refers to constipation that is persistent but can

Latest news

  • Clinch the deal

    The two pharma giants were working on similar, complementary lines and the merger should deliver considerable synergy benefits as well as cost savings - a necessary step for both companies if they ... The UCB-Schwarz Pharma deal will yield synergy

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Brexit and Pharma: A match made in hell.

    Brexit and Pharma: A match made in hell. My husband and I woke up in the early hours of 24 June 2016 to the astonishing news that the UK had voted ... Having worked in multiple European and Global roles across the UK and Ireland, I have seen pharma

  • Synergy Vision

    Our synergy of pharma and agency experience means that we offer a unique perspective, understand our clients and can deliver bespoke medical communications. ... Synergy Vision’ s Managing Director, Ffyona Dawber, encourages NHS, pharma and agency staff

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...